Patents by Inventor Eeva-Liisa Syvaoja

Eeva-Liisa Syvaoja has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of promoting tolerogenic immune responses and compositions therefor
    Patent number: 7172756
    Abstract: Methods and compositions for promoting tolerogenic immune responses or treating immune responses to food antigens comprise Lactobacillus GG. Oral administration of Lactobacillus GG to patients such as human infants may promote a tolerogenic immune response to antigens in cow's milk.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: February 6, 2007
    Assignee: Valio Oy
    Inventors: Erika Isolauri, Leena Metsäniitty, Hannu Korhonen, Seppo Salminen, Eeva-Liisa Syvaoja
  • Methods of promoting tolerogenic immune responses and compositions therefor
    Publication number: 20030113340
    Abstract: Methods and compositions for promoting tolerogenic immune responses or treating immune responses to food antigens comprise Lactobacillus GG. Oral administration of Lactobacillus GG to patients such as human infants may promote a tolerogenic immune response to antigens in cow's milk.
    Type: Application
    Filed: December 18, 2002
    Publication date: June 19, 2003
    Applicant: Valio Oy
    Inventors: Erika Isolauri, Leena Metsaniitty, Hannu Korhonen, Seppo Salminen, Eeva-Liisa Syvaoja
  • Methods of preventing or treating allergies
    Patent number: 6506380
    Abstract: The present invention provides method of making a protein hydrolysate formula and protein hydrolysate formulas made thereby for downregulating hypersensitivity and for promoting gut immune barrier, and methods of preventing or treating allergies, especially cow's milk allergy by combining the protein with probiotic gastrointestinal bacteria, especially Lactobacilli. The probiotics make it possible to influence the immunological balance, whereby allergy can be prevented by affecting the initiation mechanism of allergy. The present invention makes it possible to develop a person's tolerance of proteins by actively promoting a tolerogenic immune response. In addition, present invention provides for administering fragments of an allergen modified by probiotic gastrointestinal bacteria in order to desensitize a immune response to systemic hyporesponsiveness.
    Type: Grant
    Filed: May 29, 1998
    Date of Patent: January 14, 2003
    Assignee: Valio Oy
    Inventors: Erika Isolauri, Leena Metsäniitty, Hannu Korhonen, Seppo Salminen, Eeva-Liisa Syväoja
  • Method of encapsulating biologically active substances with mucin, a capsule produced by the method, and a fodder containing such capsules
    Patent number: 5104662
    Abstract: The invention relates to a method of encapsulating biologically active substances by gelling them with intestinal mucus (mucin). The invention is also concerned with a capsule produced by the method, its use as a fodder admixture, and a fodder containing such capsules.
    Type: Grant
    Filed: October 16, 1990
    Date of Patent: April 14, 1992
    Assignee: Valio Meijerien Keskusosuusliike
    Inventors: Hannu Kalsta, Eeva-Liisa Syvaoja, Juha Nousiainen, Jouko Setala